Bank of Montreal
ITOS

Bank of Montreal’s iTeos Therapeutics ITOS Stock Holding History

Bank of Montreal’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,485
Closed -$249K – 4048
2024
Q2 		$249K Buy
+16,485
New +$236K ﹤0.01% 2854
2023
Q3 		– Sell
-171,389
Closed -$3.1M – 4024
2023
Q2 		$3.1M Buy
+171,389
New +$2.44M ﹤0.01% 1573
2021
Q2 		– Sell
-685
Closed -$21K – 4281
2021
Q1 		$21K Sell
685
-1,067
-61% -$38.6K ﹤0.01% 4030
2020
Q4 		$57K Buy
1,752
+1,256
+253% +$33.3K ﹤0.01% 3879
2020
Q3 		$11K Buy
+496
New +$13.3K ﹤0.01% 4092

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of Montreal's ITOS Position: Q3 2024 in Review

Bank of Montreal sold out of iTeos Therapeutics (ITOS) in Q3 2024, closing a stake of 16,485 shares — an estimated $249K sold.

Bank of Montreal first reported a position in ITOS in Q3 2020 and held it in 5 quarters. The position peaked at $3.1M in Q2 2023. 151 funds tracked by Wall St. Rank hold ITOS as of Q3 2024.

  • Bank of Montreal reported no remaining iTeos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 16,485 iTeos Therapeutics shares in Q3 2024, an estimated $249K.
  • Bank of Montreal first reported a position in iTeos Therapeutics in Q3 2020 and held it in 5 quarters.
  • Bank of Montreal's iTeos Therapeutics position peaked at $3.1M in Q2 2023.
  • 151 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.